|
Vericiguat Clinical Trials
4 actively recruiting trials across 1 location
Also known as: MK-1242, Verquvo
Pipeline
Phase 2: 1Phase 4: 2
Top Sponsors
- Vanderbilt University Medical Center1
- University of Alberta1
- University Medical Centre Ljubljana1
- Guangdong Provincial People's Hospital1
Indications
- Heart Disease4
- Heart Failure2
- Brain Disease1
- Heart Failure With Reduced Ejection Fraction (HFrEF)1
- Hemodialysis Complication1
Other3 trials
Nashville, Tennessee1 trial
SGC Stimulation, Perioperative Vascular Reactivity, and Organ Injury in Cardiac Surgery
Vanderbilt University Medical Center
Phase 4
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.